Biogen names Jane Grogan as head of research

Jane Grogan has been named as executive vice president, head of research at US biotech major Biogen (Nasdaq: BIIB), with the appointment taking effective on October 2.

Dr Grogan will also become a member of Biogen’s executive committee reporting to president and chief executive Christopher Viehbacher, President and Chief Executive Officer.

“Dr Grogan is a pioneering scientist whose ground-breaking discoveries at Genentech helped pave the way for development of targeted autoimmune and oncology therapies. I believe Jane will be a strong asset to Biogen as we seek to bring a greater number of innovative medicines to market faster and more effectively,” said Mr Viehbacher, adding: “Together with Dr Priya Singhal, EVP and head of development, she will determine the company’s portfolio strategy with the aim of creating value and making decisions aligned with our scientific expertise and translational capabilities.”